JP2007502283A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007502283A5 JP2007502283A5 JP2006523322A JP2006523322A JP2007502283A5 JP 2007502283 A5 JP2007502283 A5 JP 2007502283A5 JP 2006523322 A JP2006523322 A JP 2006523322A JP 2006523322 A JP2006523322 A JP 2006523322A JP 2007502283 A5 JP2007502283 A5 JP 2007502283A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkyl
- cycloalkyl
- aryl
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 0 *c(ccc(**CN(*)*)c1)c1N(*)C(N(*)*)=O Chemical compound *c(ccc(**CN(*)*)c1)c1N(*)C(N(*)*)=O 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49485503P | 2003-08-13 | 2003-08-13 | |
| PCT/US2004/025970 WO2005019240A2 (en) | 2003-08-13 | 2004-08-11 | Melanin concentrating hormone receptor antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007502283A JP2007502283A (ja) | 2007-02-08 |
| JP2007502283A5 true JP2007502283A5 (https=) | 2007-06-28 |
Family
ID=34215905
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006523322A Withdrawn JP2007502283A (ja) | 2003-08-13 | 2004-08-11 | メラニン凝集ホルモン受容体アンタゴニスト |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20050256161A1 (https=) |
| EP (1) | EP1654225A4 (https=) |
| JP (1) | JP2007502283A (https=) |
| AU (1) | AU2004266228A1 (https=) |
| CA (1) | CA2534428A1 (https=) |
| MX (1) | MXPA06001638A (https=) |
| WO (1) | WO2005019240A2 (https=) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100418965C (zh) | 2003-08-15 | 2008-09-17 | 万有制药株式会社 | 咪唑并吡啶衍生物 |
| US7550499B2 (en) * | 2004-05-12 | 2009-06-23 | Bristol-Myers Squibb Company | Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| EP1954696B1 (en) * | 2005-01-19 | 2011-02-23 | Bristol-Myers Squibb Company | 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders |
| AU2006232871B9 (en) * | 2005-04-01 | 2011-11-24 | Eli Lilly And Company | Histamine H3 receptor agents, preparation and therapeutic uses |
| EP1899299B1 (en) * | 2005-06-27 | 2010-10-20 | Bristol-Myers Squibb Company | C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| DE602006020871D1 (de) * | 2005-06-27 | 2011-05-05 | Bristol Myers Squibb Co | Lineare harnstoffmimetika-antagonisten des p2y1-rezeptors zur behandlung von thromboseleiden |
| WO2007002634A1 (en) * | 2005-06-27 | 2007-01-04 | Bristol-Myers Squibb Company | Carbocycle and heterocycle antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| AR056867A1 (es) * | 2005-06-27 | 2007-10-31 | Bristol Myers Squibb Co | Antagonistas heterociclicos n- enlazados del receptor de p2y1 utiles en el tratamiento de condiciones tromboticas. composiciones farmaceuticas. |
| CN101273026A (zh) | 2005-09-30 | 2008-09-24 | 霍夫曼-拉罗奇有限公司 | 作为mch受体拮抗剂的茚满衍生物 |
| JP2010500300A (ja) | 2006-08-08 | 2010-01-07 | サノフィ−アベンティス | アリールアミノアリール−アルキル−置換イミダゾリジン−２，４−ジオン、それらの製造法、それらの化合物を含有する薬剤、およびそれらの使用 |
| US7960569B2 (en) * | 2006-10-17 | 2011-06-14 | Bristol-Myers Squibb Company | Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| WO2010003624A2 (en) | 2008-07-09 | 2010-01-14 | Sanofi-Aventis | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
| US20100222381A1 (en) | 2009-02-27 | 2010-09-02 | Hariprasad Vankayalapati | Cyclopentathiophene/cyclohexathiophene DNA methyltransferase inhibitors |
| MX2012001729A (es) | 2009-08-26 | 2012-06-13 | Sanofi Sa | Nuevos hidratos cristalinos de fluoroglicosido heteroaromatico, productos farmaceuticos que comprenden estos compuestos, y su empleo. |
| AU2011329233A1 (en) | 2010-11-15 | 2013-05-23 | Abbvie Deutschland Gmbh & Co Kg | NAMPT and ROCK inhibitors |
| EP2683699B1 (de) | 2011-03-08 | 2015-06-24 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| EP2683698B1 (de) | 2011-03-08 | 2017-10-04 | Sanofi | Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| EP2683702B1 (de) | 2011-03-08 | 2014-12-24 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| EP2683705B1 (de) | 2011-03-08 | 2015-04-22 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| US8828995B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| EP2683701B1 (de) | 2011-03-08 | 2014-12-24 | Sanofi | Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| US8895547B2 (en) | 2011-03-08 | 2014-11-25 | Sanofi | Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
| US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
| WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| HU230880B1 (hu) | 2015-04-15 | 2018-11-29 | Richter Gedeon Nyrt | Indol származékok |
| AU2016247768B2 (en) * | 2015-04-17 | 2019-03-07 | Corteva Agriscience Llc | Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto |
| CN107949279A (zh) * | 2015-07-06 | 2018-04-20 | 得克萨斯系统大学评议会 | 可用作用于治疗人类癌症的抗癌剂的苯甲酰胺或苯扎明化合物 |
| BR112019006746B8 (pt) * | 2016-10-12 | 2022-09-06 | Dow Agrosciences Llc | Molécula apresentando utilidade pesticida, composição, e processos para controle de pragas |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2730174C2 (de) * | 1977-07-04 | 1981-12-10 | Ludwig Merckle Kg Chem. Pharm. Fabrik, 7902 Blaubeuren | Aminobenzoesäurederivate und Arzneimittel enthaltend solche Aminobenzoesäurederivate |
| JPS6034993A (ja) * | 1983-05-23 | 1985-02-22 | ユーエスヴイー フアーマシユーテイカル コーポレーシヨン | 高血圧治療用化合物 |
| GB0001447D0 (en) * | 2000-01-21 | 2000-03-08 | Novartis Ag | Organic compounds |
| HK1054390B (en) * | 2000-12-22 | 2006-01-06 | Schering Corporation | Piperidine mch antagonists and their use in the treatment of obesity |
| DE10123958A1 (de) * | 2001-05-17 | 2002-11-28 | Aventis Pharma Gmbh | Verfahren zur Identifizierung von Liganden für G protein coupled receptors |
| PE20021091A1 (es) * | 2001-05-25 | 2003-02-04 | Aventis Pharma Gmbh | Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion |
| US6552188B2 (en) * | 2001-06-29 | 2003-04-22 | Kowa Co., Ltd. | Unsymmetrical cyclic diamine compound |
| DE10139416A1 (de) * | 2001-08-17 | 2003-03-06 | Aventis Pharma Gmbh | Aminoalkyl substituierte aromatische Bicyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| CA2468015A1 (en) * | 2001-11-27 | 2003-06-05 | Merck & Co., Inc. | 2-aminoquinoline compounds |
| US6818772B2 (en) * | 2002-02-22 | 2004-11-16 | Abbott Laboratories | Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor |
| WO2003087046A1 (en) * | 2002-04-09 | 2003-10-23 | 7Tm Pharma A/S | Novel aminotetraline compounds for use in mch receptor related disorders |
| AU2003226927A1 (en) * | 2002-04-09 | 2003-10-27 | 7Tm Pharma A/S | Novel carboxamide compounds for use in mch receptor related disorders |
| US7078430B2 (en) * | 2002-07-08 | 2006-07-18 | Ranbaxy Laboratories Limited | HMG CoA-reductase inhibitors |
| FR2842524B1 (fr) * | 2002-07-16 | 2005-04-22 | Aventis Pharma Sa | Compositions pharmaceutiques contenant un derive de 3-guanidinocarbonyl-1-heteroaryl-pyrrole, leur procede de preparation a titre de medicaments |
| US7091235B2 (en) * | 2002-10-15 | 2006-08-15 | Signal Pharmaceuticals, Llc | Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer |
-
2004
- 2004-08-11 AU AU2004266228A patent/AU2004266228A1/en not_active Abandoned
- 2004-08-11 MX MXPA06001638A patent/MXPA06001638A/es active IP Right Grant
- 2004-08-11 WO PCT/US2004/025970 patent/WO2005019240A2/en not_active Ceased
- 2004-08-11 EP EP04780754A patent/EP1654225A4/en not_active Withdrawn
- 2004-08-11 JP JP2006523322A patent/JP2007502283A/ja not_active Withdrawn
- 2004-08-11 CA CA002534428A patent/CA2534428A1/en not_active Abandoned
- 2004-08-11 US US10/916,219 patent/US20050256161A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007502283A5 (https=) | ||
| JP6193922B2 (ja) | ハロアルキルヘテロアリールベンズアミド化合物 | |
| ES2873949T3 (es) | Moduladores del receptor de glucocorticoides de azadecalina condensada con heteroaril-cetona | |
| TW444013B (en) | Quinoline and quinazoline compounds useful in treating benign prostatic hyperplasia | |
| RU2010129724A (ru) | 4-(4-циано-2-тиоарил)-дигидропиримидиноны и их применение | |
| RU2007111711A (ru) | Производные трициклического лактама в качестве ингибиторов 11-бэта-гидроксистероидной дегидрогеназы | |
| DE69208263T2 (de) | Substituierte aminopyrimidine als angiotensin ii antagonisten | |
| RU2009113585A (ru) | Производные дибензофурана в качестве ингибиторов pde-4 и pde-10 | |
| JP2007502287A5 (https=) | ||
| JP2016053078A (ja) | がん及び非新生物性状態の治療方法 | |
| JP2013542996A5 (https=) | ||
| JP2010502689A5 (https=) | ||
| JO3429B1 (ar) | مشتقات برميدينات مثبطة فيروس الايدز | |
| JP2005523254A5 (https=) | ||
| JP2011507878A5 (https=) | ||
| RU2010147404A (ru) | Замещенные дигидропиразолоны в качестве ингибиторов hif-пролил-4-гидроксилазы | |
| JP2007530601A5 (https=) | ||
| JP2972377B2 (ja) | カテコール誘導体、その薬学的に許容しうる塩およびエステルならびにそれらを含有する医薬組成物 | |
| CN1997366A (zh) | 作为抗病毒剂的咪唑和噻唑衍生物 | |
| JP2011507879A5 (https=) | ||
| AU2015346413A1 (en) | Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof | |
| JP2020500866A5 (https=) | ||
| JP2014514290A5 (https=) | ||
| JP2005506982A5 (https=) | ||
| US20090298872A1 (en) | Compounds and compositions as modulators of steroidal receptors and calcium channel activities |